4th Quarter - Report

AVENUE SOLUTIONS for JAZZ PHARMACEUTICALS, INC.

Firm
Client
Income
$80,000
Expenses
—

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Drug safety issues; Prescription drug abuse; Monitor drug pricing legislation; H.R. 987, Strengthening Health Care and Lowering Prescription Drug Costs Act; S. 1895, Lower Health Care Costs Act; S. 1416, Affordable Prescriptions for Patients Act of 2019; H.R. 5133, Affordable Prescriptions for Patients Through Promoting Competition Act of 2019; H.R. 3, Elijah E. Cummings Lower Drug Costs Now Act; Public Law 116-136, CARES Act; H.R. 1425, Patient Protection and Affordable Care Enhancement Act (PPACEA); Issues related to Priority Review Voucher extension; H.R. 6800, The Heroes Act; H.R. 925, The Heroes Act; H.R. 133, Consolidated Appropriations Act, 2021 (Public Law 116-260)

LobbyistCovered position, as disclosed
TRACY SPICER —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 925 (116th), H.R. 987 (116th), S. 1895 (116th), H.R. 5133 (116th), H.R. 6800 (116th), H.R. 1425 (116th), S. 1416 (116th), H.R. 3 (116th), H.R. 133 (116th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.